Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis

计划入组 50 人 · 首次发布于 2026 年 5 月 1 日

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

计划入组 750 人 · 首次发布于 2025 年 8 月 27 日

(PROSPECTOR) Screening Study Evaluating the Prevalence of the KIT D816V Mutation in Patients With Systemic Mast Cell Activation

计划入组 379 人 · 首次发布于 2021 年 3 月 23 日

HT-KIT

KIT-13

C₄₃H₈₀NO₇P

KIT-2014

KIT COSMETICS PTY LTD

Australia

BEST DENTAL KIT LLC

United States

Cogent Biosciences

United States

NICE Recommends Blueprint Medicines' Ayvakyt for Advanced Systemic Mastocytosis on NHS

Cogent Bio Presents Bezuclastinib Data Highlighting Long-Term Benefits in Non-Advanced Systemic Mastocytosis

Hoth Therapeutics' HT-KIT Shows Promising Preclinical Results in KIT-Driven Cancers